TITAN PHARMACEUTICALS INC
Biological Products, (No Diagnostic Substances) · 400 OYSTER POINT BLVD, SUITE 505, SAN FRANCISCO, CA 94080
官方登記資料
0位追蹤者
2015成立於
關於 TITAN PHARMACEUTICALS INC
Titan Pharmaceuticals, Inc. is a biopharmaceutical company based in San Francisco, CA, developing proprietary therapeutics primarily for treating central nervous system ("CNS") disorders. In September 2018, Titan Pharmaceuticals underwent an IPO wherein it raised $9.5 million in gross proceeds. In the same month, it also posted approximately $1.7 million in revenue, in large part drawn from its licensing for its European intellectual property rights for Probuphine to the Italian pharmaceutical company Molteni – a leading European opioid manufacturer and also a subsidiary of the German Pharmaceutical juggernaut Merck Group.
Source: Wikipedia
產業Biological Products, (No Diagnostic Substances)
總部400 OYSTER POINT BLVD, SUITE 505, SAN FRANCISCO, CA 94080
成立時間2015
法律形式C Corporation
狀態營運中
專利6 項專利
IMPLANTS FOR RELEASE OF LIPOPHILIC OR AMPHIPHILIC PHARMACEUTICAL SUBSTANCESJP2025069303A · 2025
LOADABLE POROUS STRUCTURES FOR USE AS IMPLANTSJP2024133539A · 2024
關鍵數據
法律資訊
| 法定名稱 | TITAN PHARMACEUTICALS INC |
|---|---|
| 法律形式 | C Corporation |
| SEC CIK | 910267在 SEC EDGAR 上查看 ↗ |
| EIN | 94-3171940 |
| 產業代碼(SIC) | 2836 |
| 登記地址 | 400 OYSTER POINT BLVD, SUITE 505, SAN FRANCISCO, CA 94080 |
| 狀態 | 營運中 |
來源: SEC EDGAR · 更新於 2026年10月15日
聯絡方式與連結
地點
400 OYSTER POINT BLVD, SUITE 505, SAN FRANCISCO, CA 94080
這是你的公司嗎?
免費認領此頁面,即可新增標誌、產品、照片與職缺,並回覆評論。
認領此頁面